CLOs on the Move

Michell Consulting Group Inc

www.michellgroup.net

 
Michell Consulting Group Inc is a Miami, FL-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

First Recovery Services Inc

First Recovery Services Inc is a Huntington Station, NY-based company in the Business Services sector.

Schallert and Associates

Schallert and Associates is a Sorrento, FL-based company in the Business Services sector.

MHz Design Communications

MHz Design Communications is one of the leading companies in Business Services industry. MHz Design Communications is based in Toronto, ON. You can find more information on MHz Design Communications at www.mhzdesign.com

InterCloud

InterCloud is a leading Software-Defined Cloud Interconnect (SDCI) provider that transforms global connectivity, reduces network complexity and accelerates growth and innovation for global business – securely, quickly and easily. Its end-to-end global connectivity platform eliminates the complexity in deploying the cloud, giving businesses full control over the security, sovereignty and performance of their critical data traffic with complete peace of mind. The companys platform is underpinned by its team of cloud experts who guide customers to implement effective strategies to leverage the power of the cloud across their organisation – giving customers the ultimate peace of mind that their business will be fit for future.

DRI Healthcare

DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Over the course of three decades, we have been a trusted partner of royalty sellers and demonstrated strong execution, building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. That foundation sets us apart as we continue developing solutions for innovators while building and managing a risk-mitigated portfolio of therapeutic assets that generates attractive returns and growth potential for investors. We have deployed more than $2.5 billion, acquiring more than 70 royalties on 40-plus drugs.